Article
American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) Mutation testing for patients with advanced non-small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 20 May 2011
Keedy Vicki Leigh, Temin Sarah, Somerfield Mark R, Beasley Mary Beth, Johnson David H, McShane Lisa M, Milton Daniel T, Strawn John R, Wakelee Heather A, Giaccone Giuseppe
Abstract excerpt
PURPOSE: An American Society of Clinical Oncology (ASCO) provisional clinical opinion (PCO) offers timely clinical direction to ASCO's membership following publication or presentation of potentially practice-changing data from major studies. This PCO addresses the clinical utility of using epider...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.